Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342001 · ClinicalTrials.gov registry record · Phase 4
Hypothyroidism Treated With Calcitonin
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT03342001 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 11 participants.
The verdict
NCT03342001, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.
Interventions
- DRUG Calcitonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2019-08-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03342001
The ClinicalTrials.gov registry entry for NCT03342001 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcitonin is the first listed.
NCT03342001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03342001 about?
NCT03342001 is a clinical study titled "Hypothyroidism Treated With Calcitonin". Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.
What is the current status of trial NCT03342001?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2018-06-18. Estimated completion is 2019-08-14.
What interventions are being tested in trial NCT03342001?
The interventions under investigation include: Calcitonin (DRUG).
Who is sponsoring clinical trial NCT03342001?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.